North America Radiotherapy Market Size and Growth 2031

The North America radiotherapy market size is projected to reach US$ 8.46 billion by 2031 from US$ 3.85 billion in 2023. The market is expected to register a CAGR of 10.3% during 2023–2031. The rising prevalence of cancer globally is likely to remain a trend in the market.

North America Radiotherapy Market Analysis

Radiation therapy or radiotherapy is a type of cancer treatment. Intense energy beams are used in this treatment to eradicate cancer cells while shielding surrounding healthy tissues from radiation exposure. X-rays are often used in radiation therapy. However, many other forms of radiation therapy, such as proton radiation, are also gaining traction.

Players in the market should expect to see a broad range of growth opportunities due to the improving reimbursement scenario and growing government and private investments to meet the growing demand for cancer treatment. For example, 3.05 million Americans received radiation therapy in 2016, and that number is predicted to rise by ~37% to 4.17 million by 2040.

North America Radiotherapy Market Overview

The increasing adoption of advanced medical devices, technological advancements, and the rising prevalence of cancer are a few factors projected to boost the market growth in the coming years. Growing digitalization of medical devices, increasing adoption of advanced medical device technologies, growing emphasis on improving treatment outcomes, and rising prevalence of cancer are the factors likely drive the market growth. According to a study published by the American Cancer Society in 2024, approximately 13,820 women in the US were diagnosed with cervical cancer.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

North America Radiotherapy Market: Strategic Insights

North America Radiotherapy Market

• 
  CAGR (2023 - 2031)

  10.3%
• Market Size 2023
  US$ 3.85 billion
• Market Size 2031
  US$ 8.46 billion

Market Dynamics

GROWTH DRIVERS

• Rising Prevalence of Cancer

FUTURE TRENDS

• Increasing Number of Conferences and Symposiums to Boost Awareness About Radiation Therapy

OPPORTUNITIES

• Cancer Screening Programs and Implementation of Standard Guidelines

Key Players

• Siemens Healthineers AG
• Accuray Incorporated
• Sumitomo Heavy Industries Ltd
• Elekta AB
• Hitachi Ltd
• Koninklijke Philips NV
• Brainlab AG
• PROTOM INTERNATIONAL

Regional Overview

• North America

Market Segmentation

Type

• Products
• Software

Application

• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Colorectal Cancer
• Lymphoma
• Liver Cancer
• Thyroid Cancer
• Brain Cancer
• Cervical Cancer
• Spine Cancer
• Others

End User

• Hospitals
• Radiation Therapy Centers
• Specialty Clinics

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

North America Radiotherapy Market Drivers and Opportunities

Increasing Number of Conferences and Symposiums to Boost Awareness About Radiation Therapy

In the last few years, there has been an increase in investments in research activities focused on early detection of cancer, as well as the development of new technologies for cancer treatment and management. The education & research centers, healthcare authorities, and market players actively participate in numerous conferences and symposiums to share knowledge and showcase new technologies. In addition, such programs are prominently contributing to the spread of awareness about radiation therapy. The Ivy Brain Tumor Center at Barrow Neurological Institute held a radiation therapy symposium in March 2024 to offer attendees a chance to extend their knowledge and proficiency in the most recent procedures and therapies associated with radiation oncology and other related fields. Further, the American Society of Radiologic Technologists will announce its plan to propose Radiation Therapy Conference 2024 in September 2024. Leading radiation oncology professionals across the globe, including radiation therapists and medical dosimetrists, will attend the ASRT Radiation Therapy Conference to discuss innovation and the future of the field. The conference will allow the therapists to share their ideas and new aspects of radiation therapy. In addition, in July 2022, the University of Maryland School of Medicine conducted a symposium on practical AI in radiation oncology. Such conferences and meetings boost innovation and new product developments across the globe. Thus, the increasing number of conferences and symposiums to boost awareness about radiation therapy drives the North America radiotherapy market

Cancer Screening Programs and Implementation of Standard Guidelines

The implementation of preventive healthcare and disease diagnosis programs is growing across North America. For instance, all provinces in Canada have breast cancer screening programs for women aged 50–74 years. The Provincial Health Services Authority of British Columbia has a breast cancer screening program that offers simple, inexpensive tests to a large population base; the program mainly aims toward the early diagnosis of breast cancer. Moreover, in November 2020, the WHO announced the initiation of a strategic program to accelerate the elimination of cervical cancer. The organization announced three key steps to achieve the objective: vaccination, screening, and treatment.

Further, the CDC is one of 19 national organizations that are members of the Comprehensive Cancer Control National Partnership (CCCNP). Its main goal is to support comprehensive cancer control coalitions in states, territories, tribes, and U.S. Pacific Island jurisdictions. Such programs will likely boost cancer detection, supporting a favorable environment for adopting radiotherapy across the region.

Governments and healthcare organizations are focusing on implementing strategic guidelines and policies. For instance, in March 2021, the International Atomic Energy Agency (IAEA) and the WHO collaborated to issue new guidelines for procuring radiotherapy to improve access to radiotherapy worldwide. These new technical guidelines focus on selecting radiotherapy equipment, its utilization, and quality maintenance by healthcare facilities. The organizations issued these guidelines to increase the adoption and awareness of radiotherapy in low and middle-income countries.

Thus, cancer screening programs and the implementation of standard guidelines are projected to serve as lucrative opportunities for the growth of the North America radiotherapy market during the forecast period.

North America Radiotherapy Market Report Segmentation Analysis

Key segments that contributed to the derivation of the North America radiotherapy market analysis are type, application, and end user.

• Based on type, the North America radiotherapy market is divided into products and software. The products segment held a larger market share in 2023.
• Based on application, the market is segmented into breast cancer, lung cancer, prostate cancer, colorectal cancer, lymphoma, liver cancer, thyroid cancer, brain cancer, cervical cancer, spine cancer, and others. The breast cancer segment held the largest share in 2023.
• In terms of end user, the market is segmented into hospitals, radiation therapy centers, and specialty clinics. The hospitals segment dominated the market in 2023.

North America Radiotherapy Market Share Analysis by Geography

The geographic scope of the North America radiotherapy market report is mainly divided into three countries: the US, Canada, and Mexico. Key factors driving the market include rising cancer prevalence and an increasing number of conferences and symposiums to boost awareness about radiation therapy.

North America Radiotherapy Market Report Scope

North America Radiotherapy Market News and Recent Developments

The North America radiotherapy market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the North America radiotherapy market are listed below:

• Elekta announced that Comprehensive Motion Management (CMM) with True Tracking and automatic gating for its Elekta Unity MR-Linac had received U.S. FDA 510(k) clearance. True Tracking represents a milestone in the history of radiotherapy. For the first time in the U.S., Elekta Unity can continuously calculate the movement of the tumor anywhere in the body and account for it automatically. This functionality will allow clinicians to utilize the enhanced adaptive radiation therapy workflow to deal with moving organs and treat patients more accurately. (Source: Elekta, Press Release, February 2023)
• The International Atomic Energy Agency (IAEA) joined forces with Siemens Healthineers to strengthen cancer diagnosis and treatment capacity in low- and middle-income countries, harnessing each other’s technical expertise in new ways to combat the rising global burden of this disease that kills millions of people every year. (Source: Siemens Healthineers, Newsletter, September 2023)

North America Radiotherapy Market Report Coverage and Deliverables

The “North America Radiotherapy Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas:

• North America Radiotherapy market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• North America Radiotherapy market trends as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• North America Radiotherapy market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the North America radiotherapy market
• Detailed company profiles